- Home
- TRVI vs NWBI Comparison
TRVI vs NWBI Comparison
Compare TRVI & NWBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRVI | NWBI |
|---|---|---|
| Founded | 2011 | 1896 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2019 | 2009 |
Fundamental Metrics
Financial Performance| Metric | TRVI | NWBI |
|---|---|---|
| Price | $17.93 | $15.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 4 |
| Target Price | ★ $21.55 | $14.50 |
| AVG Volume (30 Days) | ★ 2.2M | 1.2M |
| Earning Date | 05-05-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 5.82% |
| EPS Growth | ★ 31.91 | 16.46 |
| EPS | N/A | ★ 0.34 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $6.29 |
| Revenue Next Year | N/A | $5.06 |
| P/E Ratio | ★ N/A | $45.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.78 | $11.25 |
| 52 Week High | $19.26 | $15.46 |
Technical Indicators
Market Signals| Indicator | TRVI | NWBI |
|---|---|---|
| Relative Strength Index (RSI) | 66.24 | 62.03 |
| Support Level | $10.07 | $11.87 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 1.00 | 0.29 |
| MACD | 0.18 | 0.03 |
| Stochastic Oscillator | 77.37 | 69.08 |
Price Performance
Historical ComparisonAbout TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, non-IPF interstitial lung disease, or non-IPF ILD, and refractory chronic cough, or RCC. Haduvio is an oral extended-release formulation of nalbuphine. The Company operates and manages its business as one reportable segment. Such a segment is the business of developing and commercializing the investigational therapy Haduvio.
About NWBI Northwest Bancshares Inc.
Northwest Bancshares Inc is a stockholding company for Northwest Bank. Northwest Bank is a stock savings bank and a community-oriented financial institution, offering personal and commercial banking solutions, business services, investment management, trust services, and insurance products. It also offers consumer finance loans through a wholly-owned subsidiary. The bank's loan portfolio segment consists of personal banking and Commercial Banking loans. Personal banking includes residential mortgages, home equity loans, and other consumer loans. Commercial Banking loans consist of commercial real estate loans and commercial loans. Net interest income is the company's primary contributor to revenue.